Intelligence Unit
Special Reports
Special Events
Subscribe
Sponsored
Departments
- Leadership
- Finance
- Technology
- Physicians
- Community Hospitals
- Health Plans
- Marketing
- Quality
- Nursing
- HR
Follow Us
OIG: Medicare May End Up Overpaying for ESRD Drugs
The Office of Inspector General recommends that the Centers for Medicare & Medicaid Services develop "a more accurate method" for estimating changes in the prices of drugs such as those used to treat end-stage renal disease.